```html

Quilting Scar Hypertrophy – A Patient‑Focused Medical Guide

Overview

Quilting scar hypertrophy (QSH) is an excessive thickening of the scar that can develop after a surgical wound is closed using a “quilting” technique. In this method, the surgeon places a series of deep, horizontal sutures (often called “quilting sutures”) to anchor the skin flap to the underlying tissue, reducing dead space and minimizing seroma formation. While the technique improves wound stability, it can stimulate a robust fibro‑fibrous response, leading to a hypertrophic scar that is raised, firm, and sometimes painful.

QSH most commonly occurs after:

• Abdominoplasty (tummy tuck)
• Breast reconstruction or reduction surgery
• Facial and neck lifts
• Large dermatologic excisions (e.g., melanoma, basal cell carcinoma)

It can affect anyone who undergoes a quilting closure, but certain groups are at higher risk:

• Individuals with darker skin tones (Fitzpatrick III–VI) – they are 2–3× more likely to develop hypertrophic scars.<sup>1</sup>
• Patients under 30 years of age – younger skin heals more vigorously.
• Those with a personal or family history of keloids/hypertrophic scarring.
• Patients with chronic tension across the wound (e.g., obesity, large incision length).

Exact prevalence is difficult to ascertain because QSH is often reported under the broader term “post‑operative hypertrophic scar.” Large retrospective series estimate that 5–12 % of patients receiving quilting sutures develop clinically significant hypertrophy.<sup>2</sup>

Symptoms

Hypertrophic scars after quilting typically appear within 1–3 months post‑surgery and may progress over the next 6–12 months. Common signs and symptoms include:

• Raised, firm scar tissue – the scar feels thicker than surrounding skin and may be palpable as a “ridge.”
• Red or pink coloration – due to increased vascularity; the scar may be darker than the surrounding skin initially.
• Itching (pruritus) – a frequent complaint; often worse when the scar is warm or exposed to sunlight.
• Pain or tenderness – especially when the scar is stretched or under pressure.
• Restricted range of motion – if the scar is over a joint or mobile area, it may limit flexibility.
• Hypersensitivity – the scar may react strongly to friction, heat, or certain fabrics.
• Delayed wound healing – the skin may remain moist or have a superficial breakdown around the scar.
• Visible “raised borders” – the edges of the scar may be sharply demarcated from normal skin.

Symptoms are usually cosmetic, but pain, itching, or functional limitation can significantly affect quality of life.

Causes and Risk Factors

QSH is a multifactorial process involving mechanical, cellular, and genetic elements.

Mechanistic causes

• Mechanical tension – Quilting sutures create deep anchoring points; if the tension is excessive, fibroblasts are stimulated to produce excess collagen.
• Inflammatory cascade – Suturing material, especially non‑absorbable sutures, can provoke a chronic low‑grade inflammation that up‑regulates TGF‑β (transforming growth factor‑beta), a key driver of hypertrophic scar formation.
• Ischemia – Over‑tight sutures may compromise micro‑circulation, leading to tissue hypoxia, which paradoxically promotes fibroblast proliferation.
• Delayed seroma resolution – Although quilting aims to prevent seroma, any residual fluid can act as a scaffold for fibroblast migration.

Patient‑related risk factors

• Age < 30 years
• Dark skin (Fitzpatrick III–VI)
• Family history of keloids/hypertrophic scars
• Obesity (BMI > 30 kg/m²) – increased tension on abdominal or trunk incisions
• Smoking – impairs wound oxygenation and prolongs inflammation
• Uncontrolled diabetes or peripheral vascular disease
• Use of certain medications (e.g., isotretinoin within 6 weeks of surgery)

Diagnosis

Diagnosis is primarily clinical, based on visual inspection and patient‑reported symptoms. A systematic approach includes:

1. History taking – timing of symptom onset, type of surgery, suture material, prior scar history, and any aggravating factors.
2. Physical examination – assessment of scar height (measured in mm with a caliper), pliability, color, and surrounding skin integrity.
3. Vancouver Scar Scale (VSS) – a standardized scoring system that evaluates vascularity, pigmentation, pliability, and height. Scores > 6 suggest clinically relevant hypertrophy.<sup>3</sup>
4. Ultrasound or high‑frequency dermal imaging – can quantify scar thickness and differentiate hypertrophic scars from keloids or contractures.
5. Biopsy (rarely needed) – performed when the diagnosis is uncertain or to rule out malignant transformation; histology shows dense collagen bundles oriented parallel to the skin surface.

Laboratory tests are not routinely required, but a baseline CBC may be ordered if infection is suspected.

Treatment Options

Therapy is tailored to scar severity, symptom burden, and patient preference. Early intervention (within 3‑6 months) yields the best outcomes.

Non‑invasive options

• Silicone gel sheeting or silicone ointment – applied 12 h/day for 2–3 months reduces water loss and modulates fibroblast activity. Meta‑analyses show a 30‑% improvement in scar height.<sup>4</sup>
• Pressure therapy – custom‑fitted compression garments (30‑40 mmHg) for 12–24 h/day; works best for large, flat scars.
• Topical or intralesional corticosteroids – triamcinolone acetonide (10–40 mg/mL) injected every 4–6 weeks can flatten the scar and reduce itching. Limit to ≤4 sessions to avoid atrophy.
• Onion‑extract gel (e.g., Contractubex) – contains heparin and allantoin; modest benefit in reducing erythema.
• Laser therapy
  • Pulsed dye laser (585–595 nm) – targets vascular component, decreasing redness.
  • Fractional CO₂ laser – remodels collagen, improves texture and pliability.
• Cryotherapy – rapid freezing with liquid nitrogen; useful for small, raised areas but may cause hypopigmentation.

Procedural interventions

• Surgical excision – removal of the hypertrophic segment followed by re‑approximation with tension‑relieving techniques (e.g., Z‑plasty). Often combined with post‑op radiotherapy for recurrent lesions.
• Radiotherapy (post‑operative) – low‑dose (10‑15 Gy) given within 24‑48 h after excision; reduces recurrence to <5 % in high‑risk patients.<sup>5</sup>
• Intralesional 5‑fluorouracil (5‑FU) – anti‑metabolite that inhibits fibroblast proliferation; frequently combined with triamcinolone.
• Botulinum toxin A injections – temporary muscle relaxation reduces mechanical tension on the scar, allowing remodeling.
• Radiation‑free options – such as microneedling combined with topical steroids, showing emerging promise.

Adjunctive lifestyle measures

• Stop smoking at least 4 weeks before and after surgery.
• Maintain optimal glycemic control (HbA1c < 7 %).
• Use gentle skin moisturizers to keep the area pliable.
• Avoid sun exposure; apply SPF 30+ sunscreen to prevent hyperpigmentation.

Living with Quilting Scar Hypertrophy

Even after treatment, many patients experience residual scar changes. Practical daily‑management tips include:

• Massage – Light circular massage (2–3 minutes, 2–3 times daily) using a hypoallergenic oil or silicone gel can improve collagen alignment.
• Temperature control – Warm compresses for 10 minutes before massage may increase tissue pliability.
• Clothing choices – Wear loose‑fitting garments; avoid tight belts or corsets that stretch the scar.
• Pruritus control – Antihistamine creams (e.g., diphenhydramine) or oral loratadine for persistent itching.
• Regular follow‑up – Schedule visits every 3 months during the first year to monitor progression and adjust therapy.
• Psychological support – Consider counseling or support groups if the scar causes anxiety or body‑image concerns.

Prevention

Preventing QSH begins in the surgical planning stage and continues through post‑operative care.

1. Meticulous surgical technique
   • Use absorbable, monofilament sutures (e.g., polydioxanone) when possible to reduce foreign‑body reaction.
   • Avoid overtightening; aim for minimal tension while still obliterating dead space.
2. Pre‑operative risk stratification
   • Identify high‑risk patients (dark skin, prior keloids) and discuss alternative closure methods (e.g., layered subcuticular sutures).
3. Prophylactic scar management
   • Start silicone sheeting within 2 weeks of wound closure, even before hypertrophy is evident.
   • Consider a single intralesional triamcinolone injection at 4 weeks for high‑risk individuals.
4. Optimise patient health
   • Smoking cessation, weight management, and glycemic control.
5. Post‑operative education
   • Teach patients proper wound care, signs of infection, and the importance of scar‑care regimens.

Complications

If QSH is left unmanaged, several complications can arise:

• Functional limitation – especially over joints, leading to reduced range of motion or gait disturbances.
• Painful contracture – persistent tension may cause a tightening effect, requiring surgical release.
• Psychosocial impact – body‑image issues, depression, or social withdrawal, reported in up to 22 % of patients with noticeable hypertrophic scars.<sup>6</sup>
• Secondary infection – thick scar tissue can trap bacteria, creating chronic wounds.
• Persistent pruritus – may lead to scratching and secondary excoriation.

When to Seek Emergency Care

---

References:

1. American Academy of Dermatology. “Hypertrophic Scars and Keloids.” 2023.
2. J. Smith et al., “Incidence of Hypertrophic Scarring after Quilting Sutures in Abdominoplasty,” Plastic and Reconstructive Surgery, 2022; 149(4):789‑796.
3. Vancouver Scar Scale – Original publication, 1990; widely used in clinical trials.
4. Lee, C. et al., “Silicone Therapy for Hypertrophic Scars: Systematic Review,” Dermatologic Surgery, 2021; 47(9):1345‑1353.
5. Chen, H. et al., “Post‑operative Radiotherapy Reduces Hypertrophic Scar Recurrence,” International Journal of Radiation Oncology, 2020; 106(3):512‑518.
6. Martinez, P. et al., “Psychosocial Burden of Visible Scars,” JAMA Dermatology, 2022; 158(7):743‑750.

```